Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease　― An Observation From the REAL-CAD Study ―-Reference-Cited by-同舟云学术

Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease　― An Observation From the REAL-CAD Study ―

Published:2023-01-25 Issue:2 Volume:87 Page:360-367
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Toyota Toshiaki¹,Morimoto Takeshi²,Iimuro Satoshi³,Fujita Retsu³,Iwata Hiroshi⁴,Miyauchi Katsumi⁴,Inoue Teruo⁵,Nakagawa Yoshihisa⁶,Nishihata Yosuke⁷,Daida Hiroyuki⁴,Ozaki Yukio⁸,Suwa Satoru⁹,Sakuma Ichiro¹⁰,Furukawa Yutaka¹,Shiomi Hiroki¹¹,Watanabe Hirotoshi¹¹,Yamaji Kyohei¹¹,Saito Naritatsu¹¹,Natsuaki Masahiro¹²,Ohashi Yasuo¹³,Matsuzaki Masunori¹⁴,Nagai Ryozo¹⁵,Kimura Takeshi¹¹

Affiliation:

1. Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital

2. Department of Clinical Epidemiology, Hyogo College of Medicine

3. Innovation and Research Support Center, International University of Health and Welfare

4. Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine

5. Department of Cardiovascular Medicine, Dokkyo Medical University

6. Department of Cardiovascular Medicine, Shiga University of Medical Science

7. Department of Cardiovascular Medicine, St. Luke’s International Hospital

8. Department of Cardiology, Fujita Health University School of Medicine

9. Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital

10. Caress Sapporo Hokko Memorial Clinic

11. Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

12. Department of Cardiovascular Medicine, Saga University Hospital

13. Department of Integrated Science and Technology for Sustainable Society, Chuo University

14. St. Hill Hospital

15. Jichi Medical University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/2/87_CJ-22-0168/_pdf

Reference20 articles.

1. 1. Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, et al. High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): A randomized superiority trial. Circulation 2018; 137: 1997–2009.

2. 2. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425–1435.

3. 3. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2889–2934.

4. 4. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73: 3168–3209.

5. 5. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 111–188.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis;Cardiovascular Intervention and Therapeutics;2024-06-17